2018
DOI: 10.1016/j.diabres.2018.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Niclosamide ethanolamine improves kidney injury in db/db mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 27 publications
2
18
0
Order By: Relevance
“…Ethanolamine serum levels also increased with MetS in this study. Previous studies reported that ethanolamine may improve kidney injury in the mouse T2D model 30,31 . We speculate that enhancement of serum ethanolamine might indicate the high risk of kidney injury in these untreated patients.…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…Ethanolamine serum levels also increased with MetS in this study. Previous studies reported that ethanolamine may improve kidney injury in the mouse T2D model 30,31 . We speculate that enhancement of serum ethanolamine might indicate the high risk of kidney injury in these untreated patients.…”
Section: Discussionmentioning
confidence: 69%
“…Previous studies reported that ethanolamine may improve kidney injury in the mouse T2D model. 30,31 We speculate that enhancement of serum ethanolamine might indicate the high risk of kidney injury in these untreated patients. N,N-dimethylglycine and trimethylamine N-oxide are closely associated with elevated HbA 1c .…”
Section: Discussionmentioning
confidence: 91%
“…Excessive mitochondrial ROS levels were associated with mitochondrial injury in mice with diabetic nephropathy (Hwang et al 2012). Mice with diabetic kidney disease exhibited urinary albumin excretion (Han et al 2018(Han et al , 2019 Moreover, studies in dogs (Chacar et al 2017) and cats (Ferlizza et al 2017;Maeda et al 2015) have shown that urinary proteins are one of the early biomarkers of CKD. In addition, the ER is an organelle with several essential functions, including protein synthesis and processing (Chen et al 2010).…”
Section: Introductionmentioning
confidence: 99%
“…The potential therapeutic effect of niclosamide and its analogues has been reported in many diseases including Parkinson’s disease, cancer, type 2 diabetes, bacterial and viral infection, rheumatoid arthritis, and systemic sclerosis through multiple mechanisms such as uncoupling of oxidative phosphorylation, and modulation of Wnt/β-catenin, mTORC1, STAT3, NF-κB, and Notch signaling pathways [ 81 , 82 ]. Moreover, niclosamide and its analogues have been shown to exert renoprotective effects in various kidney models including unilateral ureteral obstruction, renal ischemia/reperfusion injury, adriamycin nephropathy, as well as db/db and STZ-induced type 1 diabetic kidney injury [ 83 , 84 , 85 , 86 , 87 ]. Despite its promising antifibrotic effect in kidney disease, the underlying mechanism is still not clear.…”
Section: Pharmacological Activation Of Pink1mentioning
confidence: 99%